Skyrizi on Prescription Blue Select (S5584-001)
risankizumab
Covered, with prior authorization required.
Tier 5 (specialty tier). Quantity limit of 2.4 per 56 days.
$2,395.04
Patient pays / month, after deductible
$2,856.29
Patient pays / month, before the $615.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
SKYRIZI Kit at a preferred retail pharmacy, from the plan's negotiated price of $9,580.14 for a month. Other covered strengths are listed below.
Prior authRequired on all 4 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 4 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| SKYRIZI 150 mg/mL Injection | 5 | $5,800.19 | PA · 1 per 28 days |
| SKYRIZI Kit | 5 | $4,868.40 | PA · 2.4 per 56 days |
| SKYRIZI Kit | 5 | $2,395.04 | PA · 2.4 per 56 days |
| SKYRIZI 150 mg/mL Injection | 5 | $5,805.73 | PA · 1 per 28 days |
Other IL-17 and IL-23 biologics on this plan
Verify with the plan before prescribing or filling. Member services: (800)565-1770. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5584-001